Anne Neumeister

Anne Neumeister

Auto-generated profile, based on publicly available information

Anne Neumeister

Department of Neurosurgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany; Comprehensive Cancer Centre Central Germany (CCCG), Jena Campus, Jena, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2014 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
PCP. Ceschi
P. Ceschi
ABA. Bohl
A. Bohl
KSK. Sternberg
K. Sternberg
ANA. Neumeister
A. Neumeister
VSVolkmar Senz
Volkmar Senz
GPGerrit Paasche
Gerrit Paasche

5 February 2024 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Open access
SKSophie Kubon
Sophie Kubon
AMAaron Lawson McLean
Aaron Lawson McLean
NENicklas Eckardt
Nicklas Eckardt
ANAnne Neumeister
Anne Neumeister
NDNazife Dinc
Nazife Dinc
FSFalko Schwarz
Falko Schwarz
This study examined the efficacy of computed tomography (CT)-based Hounsfield units (HU) as early predictors of aseptic bone necrosis, a serious post-cranioplasty complication after autologous cranioplasty. In total, 100 patients who underwent decompressive craniectomy and subsequent autologous cranioplasty were included. The radiodensity of the bone flap was evaluated in HU from CT scans at five follow-up timepoints. HU thresholds were established to predict the development of aseptic bone necrosis. HU demonstrated a declining trend throughout the follow-up period in all patients. Necrosis type I patients showed significant differences at all timepoints from 3 months post-procedure onwards, while necrosis type II patients displayed a significant decline in HU at every follow-up. Optimal thresholds with cut-off A (91.23% of initial HU) and cut-off B (78.73% of initial HU) were established to predict the occurrence of bone necrosis and the need for artificial bone replacement, respectively. Our findings demonstrated the utility of CT-based HU measurements as a simple, non-invasive tool for the early prediction of aseptic bone necrosis following autologous cranioplasty. By delineating specific HU thresholds, our study offers a valuable guide for orchestrating timely follow-ups and advising patients on the necessity of proactive interventions.

14 December 2025 in Brain and Spine
Verified
Journal Article
Open access
MLMaximilian Lindemann
Maximilian Lindemann
DJDonjetë Januzi
Donjetë Januzi
SBSabine Borowski
Sabine Borowski
ANAnne Neumeister
Anne Neumeister
DLDenise Löschner
Denise Löschner
PBPeter Baumgarten
Peter Baumgarten
Helmet treatment is a worldwide acknowledged method to improve motor function, quality of life and aesthetics in patients with plagiocephaly. The objective of this study is to assess percentile escape in head circumference in newborns receiving helmet therapy (HMT) for plagiocephaly. All patients underwent HMT over 124.32 days on average (SD = 72.56), with 3D scans (Rodin4D neo) taken of their heads before, during and after the treatment. Eight participants were excluded due to insufficient data. Ten patients were excluded for either craniosynostosis or discontinuation of helmet therapy. “German Health Interview and Examination Survey for Children and Adolescents” (KiGGS study) served as reference for the assessment of head circumference growth. Percentiles were calculated using the LMS-method. Out of 272 patients (94 females, 178 males), 238 had suitable parameters for the LMS-method. The average age at the onset of therapy was 5.99 (SD = 2.23) months, concluding at 10.06 months (SD = 3.01). The median percentile before HMT was 50.00 (SD = 39.5), which decreased significantly to 25.00 (SD = 33.84) after HMT (p < 0.001). Only 59 patients showed percentile adherence during the treatment. The mean difference in head circumference was 21.51 mm (SD = 14.81), ranging from −44.4 mm to 69.1 mm. Clinical examination revealed that the patients exhibit developmental progress consistent with respective ages. Significant decrease in head circumferential growth was observed following HMT. Even though patients did not show clinical signs of raised ICP, to ascertain the clinical relevance of this percentile escape, conducting longer follow-ups involving a larger cohort of patients is crucial.

9 April 2026 in Brain and Spine
Verified
Journal Article
Open access
AMAaron Lawson McLean
Aaron Lawson McLean
ANAnne Neumeister
Anne Neumeister
JKJulian Kahr
Julian Kahr
AMAnna C. Lawson McLean
Anna C. Lawson McLean
NDNicole Demme-Krüger
Nicole Demme-Krüger
CSChristian Senft
Christian Senft
Physician gender may influence patient comfort and communication dynamics in clinical encounters. However, empirical evidence on physician-gender preferences in procedural, high-technology specialties such as neurosurgery remains limited, particularly in outpatient care. What is the prevalence of physician-gender preferences among neurosurgical outpatients across clinical scenarios, which factors are associated, and what are the operational implications? We conducted a cross-sectional survey of 324 adult neurosurgical outpatients at a German university hospital. Respondents reported physician-gender preferences across five scenarios: consultation, examination, minor intervention, major operation, and disclosure of bad news. Multivariable logistic regression assessed demographic, clinical, and affective associations. Monte Carlo simulations estimated preference fulfilment under varying physician gender ratios. Between 32.7% and 48.1% of respondents reported a physician-gender preference. Directional preferences were evenly split between female and male physicians. Demographic factors, education, and disease category showed no consistent associations. Symptom-related worry increased preference expression for minor interventions (OR 1.65, 95% CI 1.03–2.66) but reduced it for major operations (OR 0.58, 95% CI 0.36–0.94). Male patients were less likely to express preferences in operative settings (OR 0.55, 95% CI 0.34–0.89). Simulations showed that altering workforce gender ratios changed fulfilment rates by less than two percentage points. Physician-gender preferences are common but balanced and weakly associated with patient characteristics. Emotional context rather than physician gender drives preference expression. Adjusting workforce composition offers minimal benefit; attention to situational anxiety and high-quality communication is more impactful for patient-centred neurosurgical care.

16 July 2026 in Journal of Cancer Policy
Verified
Journal Article
Open access
AMAaron Lawson McLean
Aaron Lawson McLean
JKJulian Kahr
Julian Kahr
MKMarcel A. Kamp
Marcel A. Kamp
ANAnne Neumeister
Anne Neumeister
CSChristian Senft
Christian Senft
Country-level right-to-health and health-system indicators, mapped to availability, accessibility, acceptability and quality (AAAQ) domains, are used to evaluate equitable cancer outcomes, but their disease-specific validity is uncertain. Adult brain tumours are a stringent test case: no validated screening exists, glioblastoma drives much brain-tumour mortality, and survival depends on neurosurgical and radiotherapy access, neuropathology and molecular classification. Ecological analysis of five-year net survival from CONCORD-3 (adult C71 brain tumours, diagnosed 2010-14) and histology-resolved secondary outcomes (glioblastoma, diffuse and anaplastic astrocytoma, oligodendroglioma). Exposures were 14 country-level right-to-health, AAAQ-mapped, health-system and macroeconomic indicators (10 continuous, 4 binary). Pearson and Spearman correlations used bootstrap 95% confidence intervals and, per continuous non-GDP indicator, ordinary least-squares regression adjusted for log-GDP per capita (HC3 standard errors). Significance used analytic p values with Benjamini-Hochberg false-discovery-rate (FDR) correction across the full family (96 tests). Sensitivity analyses used high-income and European subsets and income-group adjustment. Of 68 countries, 57 had adult brain survival data and 43 entered the primary analysis after excluding less reliable estimates. No association survived FDR correction at either level (smallest within-outcome q = 0.36; smallest full-family q = 0.59); the largest correlations were morphine consumption (r = +0.28, 95% CI +0.01 to +0.53), GDP per capita (+0.26, -0.03 to +0.54) and current health expenditure per capita (+0.23, -0.12 to +0.53). After log-GDP adjustment, no non-GDP indicator retained a significant association. Generic country-level AAAQ-mapped indicators did not capture neuro-oncology pathway performance and showed no FDR-robust association with adult brain tumour survival; disease-specific pathway indicators are likely required. Policy frameworks relying on macro-indicators may misallocate accountability for brain tumour outcomes. Harmonised neuro-oncology pathway indicators (time to imaging and resection, completeness of molecular diagnosis, fidelity of evidence-based chemoradiation, neuro-palliative care integration) should be considered for international cancer-system and right-to-health monitoring.